Simple Summary The progression of pancreatic cancer (PDAC) involves a series of events
transforming the phenotype of cancer cells, namely epithelial-to-mesenchymal transition …

Intraductal papillary mucinous neoplasm (IPMN) is the most common pancreatic cyst and a
precursor of pancreatic cancer (PDAC). Since PDAC has a devastatingly high mortality rate …

Pancreatic cancer (PaC) shows a clear tendency to increase in the next years and therefore
represents an important health and social challenge. Currently, there is an important need to …

Pancreatic ductal adenocarcinoma (PDAC) is lethal, and the majority of patients present with
locally advanced or metastatic disease that is not amenable to cure. Thus, with surgical …

Pancreatic cancer is known for its propensity to metastasize. Recent studies have
challenged the commonly held belief that pancreatic cancer is a stepwise process, where …

Detection and quantification of tumor-derived KRAS and NRAS mutations in plasma cell-free
DNA (cfDNA) holds great potential for cancer diagnostics and treatment response …

Background This study investigated the safety and feasibility of intraoperative portal vein
blood (PVB) collection at the time of pancreatic ductal adenocarcinoma (PDAC) resection …

Introduction: Pancreatic cancer (PC) is a highly lethal disease, in part because of early
metastasis, late diagnosis, and limited treatment options. Circulating tumor cells (CTCs) are …

Pancreatic cancer is a terminal disease with high mortality and very poor prognosis. A
sensitive and quantitative analysis of KRAS mutations in pancreatic cancer provides a tool …

Background The detection and quantification of circulating tumour cells (CTCs) in pancreatic
cancer (PC) has the potential to provide prognostic information. The aim of this review was …